TCM
PFE icon

TT Capital Management’s Pfizer PFE Stock Holding History

TT Capital Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$796K Sell
28,355
-1,150
-4% -$30.6K 0.66% 31
2025
Q4 		$735K Sell
29,505
-905
-3% -$22.8K 0.59% 32
2025
Q3 		$775K Sell
30,410
-3,050
-9% -$75.3K 0.59% 32
2025
Q2 		$811K Buy
33,460
+922
+3% +$21.5K 0.66% 29
2025
Q1 		$825K Buy
32,538
+5,725
+21% +$150K 0.69% 26
2024
Q4 		$710K Buy
+26,813
New +$727K 0.57% 33

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

TT Capital Management's PFE Position: Q1 2026 in Review

TT Capital Management reduced its Pfizer (PFE) stake by 3.9% in Q1 2026, selling an estimated $30.6K and leaving 28,355 shares worth $796K. The position accounts for 0.66% of the portfolio, ranked #31.

TT Capital Management first reported a position in PFE in Q4 2024 and has held it in 6 quarters since. The position peaked at $825K in Q1 2025. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • TT Capital Management held 28,355 shares of Pfizer worth $796K as of Q1 2026.
  • TT Capital Management sold 1,150 Pfizer shares in Q1 2026, an estimated $30.6K.
  • Pfizer made up 0.66% of TT Capital Management's portfolio in Q1 2026, its #31 holding.
  • TT Capital Management first reported a position in Pfizer in Q4 2024 and has held it in 6 quarters since.
  • TT Capital Management's Pfizer position peaked at $825K in Q1 2025.
  • 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on TT Capital Management's 13F filing for Q1 2026, filed 12 May 2026.